Inventor · disambiguated record
Serozh Avanessian
Also filed as: AVANESSIAN SEROZH
1 granted patent·11 pending applications·3 citations·filing 2002–2015
24Inventor score
Files withVALPHARMA INTERNAT S P A4VALPHARMA SA4VALDUCCI ROBERTO2VAL PHARMA S A1VALPHARMA INT S P A1
Top patents by PatentIndex Score
12 records- 0160US6994873B2Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administrationVALPHARMA SA·Filed 2002·Granted Feb 7, 2006·3 cites·8 claims
- 0249US2011045068A1Pharmaceutical formulations for the oral administration of ppiVALDUCCI ROBERTO·Filed 2008·Application pending·0 cites
- 0341US2007148253A1Modified Release Formulation of Lithium Carbonate and Method for Preparation ThereofVALPHARMA INTERNAT S P A·Filed 2006·Application pending·0 cites
- 0439US2015148324A1Formulations for the preparation of immediate release tablets for oral administration containing low-dose mifepristone, tablets thus obtained and their preparation processVALPHARMA INTERNAT S P A·Filed 2013·Application pending·0 cites
- 0538US2003181414A1Multiparticulate enteric coated and multiparticulate enteric coated prolonged release formulations containing NADHVALPHARMA SA·Filed 2003·Application pending·0 cites
- 0636US2003134906A1Modified release pharmaceutical composition containing bupropion HCI as active substanceVALPHARMA SA·Filed 2002·Application pending·0 cites
- 0735US2006039997A1Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administrationVAL PHARMA S A·Filed 2005·Application pending·0 cites
- 0833US2009263471A1Controlled Release Pharmaceutical Composition of Venlafaxine Hydrochloride, and Process for Preparation ThereofVALDUCCI ROBERTO·Filed 2006·Application pending·0 cites
- 0933US2004006103A1Use of chloroquine, hydroxychloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards HIV sensitive strains and towards HIV strains which are resistant to both nucleosidic and non-nucleosidic reverse transcriptase inhibitors and to proteases inhibitorsVALPHARMA SA·Filed 2003·Application pending·0 cites
- 1033US2016158196A1A modified-release oral pharmaceutical formulation containing gliclazideVALPHARMA INTERNAT S P A·Filed 2014·Application pending·0 cites
- 1131US2015164917A1Formulations for the preparation of immediate-release tablets for oral use containing low-dose mifepristone for the treatment of endometriosis, tablets thus obtained and their preparation processVALPHARMA INTERNAT S P A·Filed 2013·Application pending·0 cites
- 1229US2017143743A1Formulation for oral administration containing mesalazineVALPHARMA INT S P A·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Serozh Avanessian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →